FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

H Gómez

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
H Gómez; Jorge Leon; Silvia P Neciosup; Joseph A Pinto; César Samanéz; Frank Campana; Luis Casanova; Carlos A Casteñeda; Fernando Hurtado de Mendoza; Claudio Flores; Luis Vera; Carlos Vallejos
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.
H Gómez; L Mas; L Casanova; DL Pen; Sergio Santillana; S Valdivia; Jorge Otero; W Rodriguez; C Carracedo; Carlos Vallejos
Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
H Gómez; Manuel Hidalgo; L Casanova; ramon colomer; DL Pen; Jorge Otero; W Rodríguez; C Carracedo; Hernán Cortés-Funes; Carlos Vallejos
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of H Gómez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: H Gómez; Jorge Leon; Silvia P Neciosup; Joseph A Pinto; César Samanéz; Frank Campana; Luis Casanova; Carlos A Casteñeda; Fernando Hurtado de Mendoza; Claudio Flores; Luis Vera; Carlos Vallejos
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.
Hematology/oncology and stem cell therapy 2012;5(3):152-7.
1998: H Gómez; L Mas; L Casanova; DL Pen; Sergio Santillana; S Valdivia; Jorge Otero; W Rodriguez; C Carracedo; Carlos Vallejos
Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2352-8.
1998: H Gómez; Manuel Hidalgo; L Casanova; ramon colomer; DL Pen; Jorge Otero; W Rodríguez; C Carracedo; Hernán Cortés-Funes; Carlos Vallejos
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2065-9.
1998: H Gómez; ramon colomer
[Treatment of lymphoma in the aged].
Medicina clínica 1998;110(15):574-5.
1998: Daniel Castellano; Pilar Lianes; Luis Paz-Ares; Manuel Hidalgo; J A Guerra; C Gómez-Martín; H Gómez; J Calzas; Hernán Cortés-Funes
A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):457-9.
1997: Carlos Vallejos; A Solidoro; H Gómez; C Castellano; O Barriga; R Galdos; L Casanova; Jorge Otero; W Rodriguez
Ifosfamide plus cisplatin as primary chemotherapy of advanced ovarian cancer.
Gynecologic oncology 1997;67(2):168-71.
1997: Rocío García-Carbonero; Manuel Hidalgo; Luis Paz-Ares; J Calzas; H Gómez; J A Guerra; Ricardo Hitt; Javier Hornedo; ramon colomer; Hernán Cortés-Funes
Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3178-84.